Abstract
The majority of adult patients diagnosed with a primary brain tumour will receive radiotherapy as part of their management plan. This chapter aims to explore what radiotherapy is and define the various forms of radiotherapy used in the treatment of gliomas. It will give an overview of the factors involved in patient selection for different tumour grades and describe the typical radiotherapy planning and treatment pathway.
The potential acute and long-term toxicity from radiotherapy to the brain will be addressed and appropriate management and support for patient undergoing treatment described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.
Buckner JC, Shaw EG, Pugh SL, et al. Radiation plus procarbazine, CCNU and vincristine in low-grade gliomas. N Engl J Med. 2016;374(14):1344–55.
Perry JR, Laperriere N, O’Callaghan CJ, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 2017;376(11):1027–37.
Ncri.org. Clinical and translational radiotherapy research working group (CTRad) Proton beam therapy – information for a lay audience [Internet]. 2016. http://ctrad.ncri.org.uk/wp-content/uploads/2014/01/CTRad-PBT-consumer-information-Jan-2016.pdf. Accessed 29 Oct 2017.
Combs SE. Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol. 2017;19(3):12.
Harrabi SB, Bougatf N, Mohr A, et al. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther Onkol. 2016;192(11):759–69.
Kleihues P, Cavenee WK, editors. World Health Organisation classification of tumours, pathology and genetics of tumours of the nervous system. Lyon: IARC Press International Agency for Research on Cancer; 2000.
Van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31(3):344–50.
Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337–43.
Van den Bent MJ, Baumert B, Erridge S, et al. Interim results from the CATNON trial (EORTC study 26053–22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet. 2017; https://doi.org/10.1016/S0140–6736(17)31442–3.
Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Rad Oncol Biol Phys. 2002;52(2):316–24.
Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade gliomas. J Nurs Scholarsh. 2007;39(1):61–7.
Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;2012(11):Art. No.: CD006145. https://doi.org/10.1002/14651858.CD006145.pub3.
Faithful S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol (R Coll Radiol). 1998;10(4):250–4.
Nih.gov. Common terminology criteria for adverse events (CTCAE) V4.03 [Internet]. 2010. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed 29 Oct 2017.
Westbury C, Hines F, Hawkes E, et al. Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol. 2000;54:109–16.
Society and College of Radiographers. Skin care advice for patients undergoing radical external beam megavoltage radiotherapy. SCoR professional document [Internet]. 2015. https://www.sor.org/learning/document-library/skin-care-advice-patients-undergoing-radical-external-beam-megavoltage-radiotherapy-0. Accessed 25 Oct 2017.
Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360(9343):1361–8. Erratum in: Lancet 2011;377(9778):1654).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Burton, K.E. (2019). Radiotherapy. In: Oberg, I. (eds) Management of Adult Glioma in Nursing Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-76747-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-76747-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76746-8
Online ISBN: 978-3-319-76747-5
eBook Packages: MedicineMedicine (R0)